Glioblastoma, the most common type of glioma, is associated with very poor survival, so glioma epidemiology ... germline variants associated with high rates of DNA repair errors.

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

According to the Mayo Clinic, even the best treatments for glioblastoma allow for survival rates of about 14 months. Glioblastoma tops the list of aggressive brain cancers, and it affects about ...

A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...

The research “…could improve survival rates, which are currently very poor for glioblastoma patients,” Jenkins summarized. Rebecca Roberts is a science writer and communicator. She earned her PhD in ...

We found that the 10-year survival rate was 70% with the combined treatment ... that temozolomide improves overall survival in grade 2 gliomas." David Schiff, MD, lead investigator, the Harrison ...

Temozolomide with radiation therapy improved 5- and 10-year OS for patients with grade 2 gliomas. The addition ... show temozolomide improves long-term survival for this specific patient population.

It was significantly longer than the survival rate after a typical standard glioblastoma treatment, which is 15 percent, although a simple comparison cannot be made. In an analysis of 19 patients ...